Plastic changes in cellular and subcellular mechanisms are critical determinants of neurobehavioral manifestations; of nervous system function. We propose to investigate the regulation of the septohipppocampal (S-H) system by nerve growth factor (NGF). The central hypothesis is that an intrahippocampal gain of NGF function in mice enhances activity of septal cholinergic neurons in the short term and, in the long term, leads to synantic reorganization in both the medical septum/nucleus of Diagonal Band (MS/nDB) and hippocampus and, thereby neurotransmission along the S-H system. To test this hypothesis, we will use as experimental model transgenic mice harboring a targeted intrahippocampal gain of NGF function. The experiments, incorporating patch clamp recording, immunohistochemistry and PCR-Amplified Detection of Immunoreactivity (PADI), are organized into three specific aims.
Specific Aim 1 will test the hypothesis that GABAergic MS/nDB neurons are under regulation of a muscarinic tone that is maintained by cholinergic activity in the MS/nDNB.
Specific Aim 2 will test the hypothesis that a targeted activation and increase in the expression of NGF in the hippocampus leads to changes in the properties of MS/nDNB neurons that are consistent with an augmented muscarinic tone and thus activity alongthe S-H pathway.
Specific Aim 3 will employ a septohippocampal coculture system to test the hypothesis that the targeted activation of NGF is time- and activity-dependent. Inherent in testing these hypothesis is the notion that specific cellular and molecular changes can be correlated with NGF activation. Thus, in addition to the electrophysiological experiments, candidate proteins will be analyzed by a PCR-based protein detection technique in single neurons isolated by laser capture microdissection. Overall, this project will contribute to our understanding of the cellular and molecular bases underlying NGF-induced plasticity in the nervous system and explore the value of targeted gene transfer as a potential therapeutic strategy to ameliorate the debilitating consequences of cognitive dysfunction as seen in a variety of neurodegenerative conditions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS048603-02
Application #
6828223
Study Section
Molecular, Cellular and Developmental Neurosciences 2 (MDCN)
Program Officer
Mamounas, Laura
Project Start
2004-01-01
Project End
2005-12-31
Budget Start
2005-01-01
Budget End
2005-12-31
Support Year
2
Fiscal Year
2005
Total Cost
$364,219
Indirect Cost
Name
University of Rochester
Department
Pharmacology
Type
Schools of Dentistry
DUNS #
041294109
City
Rochester
State
NY
Country
United States
Zip Code
14627
Guo, Lan; Yeh, Mason L; Cuzon Carlson, Verginia C et al. (2012) Nerve growth factor in the hippocamposeptal system: evidence for activity-dependent anterograde delivery and modulation of synaptic activity. J Neurosci 32:7701-10
Gulledge, Allan T; Bucci, David J; Zhang, Sunny S et al. (2009) M1 receptors mediate cholinergic modulation of excitability in neocortical pyramidal neurons. J Neurosci 29:9888-902
Lee, Hakjoo; Raiker, Stephen J; Venkatesh, Karthik et al. (2008) Synaptic function for the Nogo-66 receptor NgR1: regulation of dendritic spine morphology and activity-dependent synaptic strength. J Neurosci 28:2753-65
Wu, Chia-wen K; Yeh, Hermes H (2005) Nerve growth factor rapidly increases muscarinic tone in mouse medial septum/diagonal band of Broca. J Neurosci 25:4232-42